MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 6.9 USD -2.54% Market Closed
Market Cap: 1B USD

Relative Value

The Relative Value of one MDXG stock under the Base Case scenario is 8.51 USD. Compared to the current market price of 6.9 USD, MiMedx Group Inc is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXG Relative Value
Base Case
8.51 USD
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
55
vs Industry
69
Median 3Y
2.9
Median 5Y
2.9
Industry
7.9
Forward
2.5
vs History
15
vs Industry
6
Median 3Y
16.6
Median 5Y
-12
Industry
23.7
Forward
16.1
vs History
34
vs Industry
10
Median 3Y
16.9
Median 5Y
-21.1
Industry
22
vs History
31
vs Industry
5
Median 3Y
16.8
Median 5Y
-20
Industry
24.3
vs History
92
vs Industry
16
Median 3Y
6
Median 5Y
6.4
Industry
3.3
vs History
61
vs Industry
61
Median 3Y
2.6
Median 5Y
2.6
Industry
8.2
Forward
2.2
vs History
61
vs Industry
61
Median 3Y
3.2
Median 5Y
3.2
Industry
10.2
vs History
69
vs Industry
7
Median 3Y
17.1
Median 5Y
18.4
Industry
6.1
Forward
8.7
vs History
58
vs Industry
7
Median 3Y
18.7
Median 5Y
19
Industry
6.5
Forward
13.2
vs History
36
vs Industry
11
Median 3Y
15.5
Median 5Y
-19.5
Industry
7.9
vs History
36
vs Industry
8
Median 3Y
15.8
Median 5Y
-18
Industry
6.3
vs History
65
vs Industry
24
Median 3Y
6.2
Median 5Y
6.4
Industry
5.7

Multiples Across Competitors

MDXG Competitors Multiples
MiMedx Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MiMedx Group Inc
NASDAQ:MDXG
1B USD 2.6 25 13.5 16.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 667 065.8 -160 014.6 -194 308.7 -192 091.4
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 092.5 -534 -581.4 -565.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.2 59.8
P/E Multiple
Earnings Growth PEG
US
MiMedx Group Inc
NASDAQ:MDXG
Average P/E: 173
25
17%
1.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 014.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBITDA: 37.4
13.5
27%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 308.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBIT: 43.3
16.6
18%
0.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 091.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A